Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients
NCT ID: NCT02560571
Last Updated: 2016-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
200 participants
INTERVENTIONAL
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The sonographic evaluation will include endometrial characteristics and myometrial invasion, pelvic findings and enlarged lymph nodes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hysteroscopic Lymphatic Mapping for Endometrial Cancer
NCT00671606
Study of the Prevalence of Endometriosis and Adenomyosis
NCT06211569
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
NCT04586959
Endometrial Malignancy in Breast Cancer Patients With or Without AUB
NCT05977829
The Role of Endometrial Blood Flow in Endometrial Cancer
NCT05034991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
all patients
all study patients will undergo ultrasound and blood test
ultrasound
blood test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound
blood test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgical candidates
Exclusion Criteria
* Contraindication for surgery
* Stage 2 and higher
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yfat kadan
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir medical center
Kfar Saba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yfat Kadan
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0142-15-MMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.